about
Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy.Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.A mechanistic pharmacokinetic model elucidating the disposition of trastuzumab emtansine (T-DM1), an antibody-drug conjugate (ADC) for treatment of metastatic breast cancer.Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.Design, Synthesis and Application of Fluorine-Labeled Taxoids as (19)F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems.Anticancer drugs from nature--natural products as a unique source of new microtubule-stabilizing agents.Exploration of fluorine chemistry at the multidisciplinary interface of chemistry and biology.EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaMacromolecules as taxane delivery systems.Antibody-drug conjugates in tumor therapy.Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies.Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.Novel Taxoid-Based Tumor-Targeting Drug Conjugates.Biotin-conjugated tumour-targeting photocytotoxic iron(III) complexes.Peptide ligation from alkoxyamine based radical addition.Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery.Design, Synthesis, and Biological Evaluations of Asymmetric Bow-Tie PAMAM Dendrimer-Based Conjugates for Tumor-Targeted Drug Delivery.
P2860
Q33894592-82D8C26D-CFA3-4E68-B094-4D6562B42707Q33925595-78FD5946-DCE0-44AF-A040-0EE08A230C8BQ34099745-B0FA489B-0141-412E-A7FB-019B1332D6B5Q34565264-CC857569-C1DA-42E8-B4D9-5697C26B3438Q35110101-EB9C4816-E4F9-490F-B1C8-A4371FFF9EF8Q36772390-6E342AB1-515F-44E6-8A2A-F9F95F404A26Q37118460-9981565D-B216-4B39-94B2-49FADEB6FEAFQ37329160-7A99BB4F-9FE8-48D7-A9E9-B9369454A5F0Q37818236-DE3E1C5E-2CD2-4D9A-A3A8-CACA781AE2AAQ38162899-47A609CB-3CB9-4341-BF5E-2A1B55D6FA85Q38694536-2FBC58B5-E4EC-4C80-B9B7-09D67C968E47Q38694867-F0213CDD-1DD3-4D62-BD7E-A047BABE3C4AQ42087874-BF91C860-246A-41EE-BE68-D867EC8004A1Q51199383-D30FB8C8-3271-4BF2-87D7-BB4A3FCBD2C2Q51756000-18804923-FABA-4BFD-9730-5DCA59697AA8Q52690917-2B548A72-AF34-4891-B786-8368FA5833FAQ54957223-4C20853C-EA74-43BA-964B-B1D4075EE551
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antibody-cytotoxic agent conjugates for cancer therapy.
@ast
Antibody-cytotoxic agent conjugates for cancer therapy.
@en
type
label
Antibody-cytotoxic agent conjugates for cancer therapy.
@ast
Antibody-cytotoxic agent conjugates for cancer therapy.
@en
prefLabel
Antibody-cytotoxic agent conjugates for cancer therapy.
@ast
Antibody-cytotoxic agent conjugates for cancer therapy.
@en
P2093
P2860
P356
P1476
Antibody-cytotoxic agent conjugates for cancer therapy.
@en
P2093
Iwao Ojima
Shuyi Chen
Stanislav Jaracz
Xianrui Zhao
P2860
P304
P356
10.1517/17425247.2.5.873
P407
P577
2005-09-01T00:00:00Z